BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20466178)

  • 21. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical tacrolimus is effective for facial lesions of psoriasis.
    Yamamoto T; Nishioka K
    Acta Derm Venereol; 2000; 80(6):451. PubMed ID: 11243645
    [No Abstract]   [Full Text] [Related]  

  • 23. Tacrolimus ointment is effective for facial and intertriginous psoriasis.
    Lebwohl M; Freeman AK; Chapman MS; Feldman SR; Hartle JE; Henning A;
    J Am Acad Dermatol; 2004 Nov; 51(5):723-30. PubMed ID: 15523350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical tacrolimus treatment for chronic dermatitis of the ear.
    Harth W; Caffier PP; Mayelzadeh B; Haupt H; Sedlmaier B; Richard G
    Eur J Dermatol; 2007; 17(5):405-11. PubMed ID: 17673384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
    Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis.
    Reitamo S; Mandelin J; Rubins A; Remitz A; Mäkelä M; Cirule K; Rubins S; Zigure S; Ho V; Dickinson J; Undre N
    Int J Dermatol; 2009 Apr; 48(4):348-55. PubMed ID: 19335418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical tacrolimus ointment may induce skin tags in treated patients.
    Sand C
    Acta Derm Venereol; 2003; 83(4):317. PubMed ID: 12926817
    [No Abstract]   [Full Text] [Related]  

  • 28. Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma.
    Schneeweiss S; Doherty M; Zhu S; Funch D; Schlienger RG; Fernandez-Vidaurre C; Seeger JD
    Dermatology; 2009; 219(1):7-21. PubMed ID: 19293564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pimecrolimus-induced rosacea-like demodicidosis.
    Yoon TY; Kim HJ; Kim MK
    Int J Dermatol; 2007 Oct; 46(10):1103-5. PubMed ID: 17910727
    [No Abstract]   [Full Text] [Related]  

  • 30. Topical tacrolimus in the treatment of granuloma faciale.
    Cecchi R; Pavesi M; Bartoli L; Brunetti L
    Int J Dermatol; 2010 Dec; 49(12):1463-5. PubMed ID: 21091691
    [No Abstract]   [Full Text] [Related]  

  • 31. Topical tacrolimus in the treatment of localized scleroderma.
    Mancuso G; Berdondini RM
    Eur J Dermatol; 2003; 13(6):590-2. PubMed ID: 14721783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facial eruption of viral warts in a child treated with 0.03% tacrolimus ointment for atopic dermatitis.
    Patrizi A; Neri I; Bianchi F; Passarini B; Ricci G
    Pediatr Dermatol; 2007; 24(4):445-7. PubMed ID: 17845188
    [No Abstract]   [Full Text] [Related]  

  • 33. Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus.
    Sugano M; Shintani Y; Kobayashi K; Sakakibara N; Isomura I; Morita A
    J Dermatol; 2006 Dec; 33(12):887-91. PubMed ID: 17169097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea.
    Chu CY
    Br J Dermatol; 2005 Feb; 152(2):396-9. PubMed ID: 15727676
    [No Abstract]   [Full Text] [Related]  

  • 35. Molluscum contagiosum in atopic dermatitis treated with 0.1% tacrolimus ointment.
    Wilson LM; Reid CM
    Australas J Dermatol; 2004 Aug; 45(3):184-5. PubMed ID: 15250900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tacrolimus ointment (Protopic) for atopic dermatitis.
    Pascual JC; Fleisher AB
    Skin Therapy Lett; 2004 Nov; 9(9):1-5. PubMed ID: 15550992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
    J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
    Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with pimecrolimus cream 1% clears irritant dermatitis of the periocular region, face and neck.
    Mensing CO; Mensing CH; Mensing H
    Int J Dermatol; 2008 Sep; 47(9):960-4. PubMed ID: 18937664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.